The purpose of this study was to assess the feasibility of @entity1600 ( @entity1600 ) biopsy in @entity259 . Ten @entity1 with uninodular @entity1374 and no evidence of lymph node @entity3 were examined. Lymph node mapping was performed by preoperative lymphoscintigraphy and intraoperative use of a hand-held gammaprobe. Following thyroidectomy, the @entity1600 (s) were selectively excised and worked-up histologically for occult @entity3 . Overall detection of SLNs was possible in 50% of the cases with lymphoscintigraphy and in 100% with the gammaprobe. All SLNs in the lateral compartment and upper mediastinum were accurately detected with lymphoscintigraphy. One @entity1 with a @entity1377 showed a @entity3 in the @entity1600 . One @entity1 experienced temporary lesion of the recurrent laryngeal nerve. In conclusion, @entity1600 biopsy is technically feasible. The combination of lymphoscintigraphy and gammaprobe accurately reveals SLNs in the central and lateral compartment and in the mediastinum. Search for SLNs in the lower central compartment enhances the risk of injuring the recurrent laryngeal nerve. The clinical relevance of @entity1600 biopsy in @entity3557 is unclear, and the subgroup of @entity1 benefiting from it has still to be defined.

Sentinel lymph node biopsy in XXXX : a pilot study.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1377 :: ('MESH:D002291', 'Disease') :: ['papillary carcinoma'] @entity3557 :: ('MESH:C536915', 'Disease') :: ['papillary thyroid cancer'] @entity1600 :: ('MESH:D014388', 'Disease') :: ['sentinel lymph node', 'SLN'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis', 'metastases'] @entity259 :: ('MESH:D013964', 'Disease') :: ['thyroid neoplasms'] @entity1374 :: ('MESH:D013959', 'Disease') :: ['thyroid disease']
@entity259 :: (MESH:D013964,Disease) :: ['thyroid tumors']
